Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print March 13, 2003, 10.1148/radiol.2272020207

(Radiology 2003;227:580.)

A more recent version of this article appeared on May 1, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, K. W.
Right arrow Articles by Lee, K.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, K. W.
Right arrow Articles by Lee, K.-H.

Acute Cholecystitis at T2-weighted and Manganese–enhanced T1-weighted MR Cholangiography: Preliminary Study1

Ki Whang Kim, MD, Mi-Suk Park, MD, Jeong-Sik Yu, MD, Jun Pyo Chung, MD, Young Hoon Ryu, MD, Sang In Lee, MD, Kwan Sik Lee, MD, Sang-Wook Yoon, MD and Kwang-Hun Lee, MD

1 From the Department of Diagnostic Radiology and Research Institute of Radiological Science (K.W.K., M.S.P., J.S.Y., Y.H.R., S.W.Y., K.H.L.) and the Department of Internal Medicine (J.P.C., S.I.L., K.S.L., H.J.P.), Yonsei University College of Medicine, YongDong Severance Hospital, 146-92 Dokok-Dong, Kangnam-Ku, Seoul 135-270, South Korea. Received March 6, 2002; revision requested April 25; final revision received August 30; accepted September 24. Address correspondence to K.W.K. (e-mail: kwkimyd@yumc.yonsei.ac.kr).



View larger version (111K):

[in a new window]
 
Figure 1a. Patient 1. (a) Coronal MR image obtained with a thin-section half-Fourier RARE sequence ({infty}/95 [effective]; flip angle, 150°) shows two cystic duct calculi (arrows). (b) Maximum intensity projection from coronal three-dimensional volumetric-interpolated T1-weighted gradient-echo image (4.2/1.6; flip angle, 12°) obtained 45 minutes after injection of mangafodipir trisodium shows the enhanced extrahepatic duct, but the gallbladder cannot be visualized. (c) Anterior hepatobiliary scintigraphic image obtained 60 minutes after injection of IDA demonstrates visualization of the extrahepatic duct (thin arrows) and small bowel (thick arrows) but fails to depict the gallbladder.

 


View larger version (136K):

[in a new window]
 
Figure 1b. Patient 1. (a) Coronal MR image obtained with a thin-section half-Fourier RARE sequence ({infty}/95 [effective]; flip angle, 150°) shows two cystic duct calculi (arrows). (b) Maximum intensity projection from coronal three-dimensional volumetric-interpolated T1-weighted gradient-echo image (4.2/1.6; flip angle, 12°) obtained 45 minutes after injection of mangafodipir trisodium shows the enhanced extrahepatic duct, but the gallbladder cannot be visualized. (c) Anterior hepatobiliary scintigraphic image obtained 60 minutes after injection of IDA demonstrates visualization of the extrahepatic duct (thin arrows) and small bowel (thick arrows) but fails to depict the gallbladder.

 


View larger version (146K):

[in a new window]
 
Figure 1c. Patient 1. (a) Coronal MR image obtained with a thin-section half-Fourier RARE sequence ({infty}/95 [effective]; flip angle, 150°) shows two cystic duct calculi (arrows). (b) Maximum intensity projection from coronal three-dimensional volumetric-interpolated T1-weighted gradient-echo image (4.2/1.6; flip angle, 12°) obtained 45 minutes after injection of mangafodipir trisodium shows the enhanced extrahepatic duct, but the gallbladder cannot be visualized. (c) Anterior hepatobiliary scintigraphic image obtained 60 minutes after injection of IDA demonstrates visualization of the extrahepatic duct (thin arrows) and small bowel (thick arrows) but fails to depict the gallbladder.

 


View larger version (122K):

[in a new window]
 
Figure 2a. Patient 6. (a) Coronal MR image obtained with a thin-section half-Fourier RARE sequence ({infty}/95 [effective]; flip angle, 150°) shows signal void lesions (arrows) in the cystic duct that are suspicious. However, they cannot be differentiated from a tortuous normal cystic duct. (b) Maximum intensity projection from coronal three-dimensional volumetric-interpolated T1-weighted gradient-echo MR image (4.2/1.6; flip angle, 12°) obtained 60 minutes after injection of mangafodipir trisodium shows the enhanced extrahepatic duct (arrows), but the gallbladder is not enhanced. (c) Anterior hepatobiliary scintigraphic image obtained 50 minutes after injection of IDA demonstrates visualization of the extrahepatic duct (thin arrow) and small bowel (thick arrows), but it does not depict the gallbladder.

 


View larger version (130K):

[in a new window]
 
Figure 2b. Patient 6. (a) Coronal MR image obtained with a thin-section half-Fourier RARE sequence ({infty}/95 [effective]; flip angle, 150°) shows signal void lesions (arrows) in the cystic duct that are suspicious. However, they cannot be differentiated from a tortuous normal cystic duct. (b) Maximum intensity projection from coronal three-dimensional volumetric-interpolated T1-weighted gradient-echo MR image (4.2/1.6; flip angle, 12°) obtained 60 minutes after injection of mangafodipir trisodium shows the enhanced extrahepatic duct (arrows), but the gallbladder is not enhanced. (c) Anterior hepatobiliary scintigraphic image obtained 50 minutes after injection of IDA demonstrates visualization of the extrahepatic duct (thin arrow) and small bowel (thick arrows), but it does not depict the gallbladder.

 


View larger version (195K):

[in a new window]
 
Figure 2c. Patient 6. (a) Coronal MR image obtained with a thin-section half-Fourier RARE sequence ({infty}/95 [effective]; flip angle, 150°) shows signal void lesions (arrows) in the cystic duct that are suspicious. However, they cannot be differentiated from a tortuous normal cystic duct. (b) Maximum intensity projection from coronal three-dimensional volumetric-interpolated T1-weighted gradient-echo MR image (4.2/1.6; flip angle, 12°) obtained 60 minutes after injection of mangafodipir trisodium shows the enhanced extrahepatic duct (arrows), but the gallbladder is not enhanced. (c) Anterior hepatobiliary scintigraphic image obtained 50 minutes after injection of IDA demonstrates visualization of the extrahepatic duct (thin arrow) and small bowel (thick arrows), but it does not depict the gallbladder.

 


View larger version (131K):

[in a new window]
 
Figure 3a. Patient 8. (a) Coronal MR image obtained with a thin-section half-Fourier RARE sequence ({infty}/95 [effective]; flip angle, 150°) shows distended gallbladder (black and white long thick arrows) and ascites (short thick arrows). The gallbladder is angulated (thin arrow) between the neck and body. There is no calculus in the gallbladder or bile duct. (b) Coronal three-dimensional volumetric-interpolated T1-weighted gradient-echo source MR cholangiographic image (4.2/1.6; flip angle, 12°) obtained 60 minutes after injection of mangafodipir trisodium shows the enhanced extrahepatic duct and neck portion (black arrow) of the gallbladder. The body and fundal portion (white arrows) of the gallbladder are not enhanced. These findings were the same at 4 hours after injection (not shown). (c) Hepatobiliary scintigraphic image in the anterior projection obtained at 60 minutes after injection of IDA demonstrates visualization of the neck portion (white arrow) of the gallbladder, the extrahepatic duct (open), and the small bowel (black arrow). The body and fundal portion of the gallbladder cannot be visualized.

 


View larger version (162K):

[in a new window]
 
Figure 3b. Patient 8. (a) Coronal MR image obtained with a thin-section half-Fourier RARE sequence ({infty}/95 [effective]; flip angle, 150°) shows distended gallbladder (black and white long thick arrows) and ascites (short thick arrows). The gallbladder is angulated (thin arrow) between the neck and body. There is no calculus in the gallbladder or bile duct. (b) Coronal three-dimensional volumetric-interpolated T1-weighted gradient-echo source MR cholangiographic image (4.2/1.6; flip angle, 12°) obtained 60 minutes after injection of mangafodipir trisodium shows the enhanced extrahepatic duct and neck portion (black arrow) of the gallbladder. The body and fundal portion (white arrows) of the gallbladder are not enhanced. These findings were the same at 4 hours after injection (not shown). (c) Hepatobiliary scintigraphic image in the anterior projection obtained at 60 minutes after injection of IDA demonstrates visualization of the neck portion (white arrow) of the gallbladder, the extrahepatic duct (open), and the small bowel (black arrow). The body and fundal portion of the gallbladder cannot be visualized.

 


View larger version (157K):

[in a new window]
 
Figure 3c. Patient 8. (a) Coronal MR image obtained with a thin-section half-Fourier RARE sequence ({infty}/95 [effective]; flip angle, 150°) shows distended gallbladder (black and white long thick arrows) and ascites (short thick arrows). The gallbladder is angulated (thin arrow) between the neck and body. There is no calculus in the gallbladder or bile duct. (b) Coronal three-dimensional volumetric-interpolated T1-weighted gradient-echo source MR cholangiographic image (4.2/1.6; flip angle, 12°) obtained 60 minutes after injection of mangafodipir trisodium shows the enhanced extrahepatic duct and neck portion (black arrow) of the gallbladder. The body and fundal portion (white arrows) of the gallbladder are not enhanced. These findings were the same at 4 hours after injection (not shown). (c) Hepatobiliary scintigraphic image in the anterior projection obtained at 60 minutes after injection of IDA demonstrates visualization of the neck portion (white arrow) of the gallbladder, the extrahepatic duct (open), and the small bowel (black arrow). The body and fundal portion of the gallbladder cannot be visualized.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2003 by the Radiological Society of North America.